BRIGATINIB

3655 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking BRIGATINIB:

# Side effect Count
0 DEATH 431
1 NON-SMALL CELL LUNG CANCER 396
2 OFF LABEL USE 307
3 DIARRHOEA 255
4 METASTASES TO CENTRAL NERVOUS SYSTEM 242
5 NAUSEA 234
6 LUNG NEOPLASM MALIGNANT 225
7 BLOOD CREATINE PHOSPHOKINASE INCREASED 220
8 FATIGUE 216
9 PRODUCT DOSE OMISSION ISSUE 204
See all common reactions for BRIGATINIB

BRIGATINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COSTOCHONDRAL SEPARATION 1 0.0909
1 CYTOKERATIN 19 INCREASED 1 0.0909
2 ANAPLASTIC LYMPHOMA KINASE GENE MUTATION 6 0.0909
3 NON-SMALL CELL LUNG CANCER 396 0.0826
4 CEREBRAL RADIATION INJURY 1 0.0714
5 PITUITARY INFARCTION 3 0.0698
6 ACID PEPTIC DISEASE 1 0.0667
7 BRAIN RADIATION NECROSIS 4 0.0541
8 MALIGNANT NERVOUS SYSTEM NEOPLASM 2 0.0488
9 LUNG ADENOCARCINOMA STAGE IV 15 0.0394
See all enriched reactions for BRIGATINIB